- 18 new behavioral health study findings to know
- How 5 systems are embedding behavioral health into clinical care
- ‘Who watches the watchmen?’ CMS tightens oversight of accrediting bodies — 8 things to know
- 8 hospital projects worth $1B+ in 2026
- UnitedHealth, FTC near insulin rebates settlement
- The hidden disparity built into healthcare interoperability
- Christus consolidates inpatient services at Texas hospital
- Health AI regulation gaps span scribes, prior authorization: 5 notes
- Is cardiac catheterization the new cataract surgery?
- CMS floats permanent status for Medicare drug price negotiations: 5 things to know
- 13 cybersecurity updates for ASC leaders to know
- The safety issue hiding in ASC staffing
- Elevance sues former chief execution officer over noncompete agreement
- 15% of pregnant women report current alcohol use: CDC
- 15% of pregnant women report current alcohol use: CDC
- California healthcare district board member resigns to apply for CEO role
- Vermont regulators greenlight new ASC
- What surgeons don’t understand about anesthesia
- National Real Estate Advisors acquires Montana medical campus with ASC, MOB
- 5 ASC, ambulatory leaders from the biggest health systems
- Ohio dentist to retire after 34 years, close practice
- Good news, bad news for DSOs
- California Health Worker Union, Hospital Association Tout Dueling Ballot Initiatives
- Nearly 13,000 dental professionals needed to fill shortage areas: HRSA
- The states with the widest anesthesiologist salary spreads
- Optum Rx, FTC posed for settlement in insulin pricing case
- 7 new behavioral health projects representing nearly $1B in investment
- How the fastest-growing DSO is expanding its network
- Program closures, practice openings & more: 5 oral surgery updates 30 days
- CMS proposes permanent framework for Medicare drug price negotiations
- Dental hygienist pay up 21% since 2021
- ‘Making a bad situation worse’: 15% of psych beds lost in 4 California counties after staffing rule
- How dentist pay has evolved over the last 5 years
- Nearly 30% of Massachusetts residents filled behavioral health prescriptions
- Rhode Island Senate advances bill creating licensure pathway for foreign-trained dentists, hygienists
- The 10 states where physician assistant pay jumped the most
- Anesthesia stipends by the numbers
- SAMHSA unveils $40M behavioral health grant funding: 5 things to know
- Best, worst states for child well-being
- 5 dental school updates to know
- 7 DSOs making headlines
- Influencers, Booze And Teens: What's Showing Up In Their Feeds?
- Health 'War Room,' Digital Tools Are Tracking Disease Risks During World Cup
- Mercer survey: Employers eye cost-shifting strategies as health benefit spend rises
- Nvidia, Abridge collaborate to develop healthcare-specific AI model
- Industry Voices—Why health systems need physicians engaged in IT leadership
- FDA hearing on Amgen's Tavneos will include findings from an independent review
- In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test
- Food Labels and Restrictions Can Lower Childhood Obesity Rates, Study Finds
- Tourette Patients Face High Suicide Risk, Pain And Discrimination
- Have A Risk-Taking Teen? This Brain Chemical Might Be Responsible, Researchers Say
- Sepsis, Lung Infection Patients See No Benefit From Remote Monitoring
- Overlooked Social Connections Can Prevent Suicide
- Final Rules for Medicaid Work Requirements Are Out. Here’s What You Need To Know.
- 1 in 4 Covered California Enrollees Could Get State Aid Under Newsom Proposal
- Lilly, Biogen, Eisai and Genentech sponsor new ‘Let’s Talk Alzheimer’s’ podcast
- Fierce Pharma Asia—Astellas CEO’s 5-year plan; Takeda’s psoriasis win; RA’s China bridge program
- Why this behavioral health provider just bought a pharmacy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- North Carolina awards $10M to expand rural behavioral healthcare access
- Healthcare costs poised to jump 9% in 2027 as health plans blame AI adoption, drug prices
- Provider groups file lawsuit against HHS over anti-trans Ryan White funding rules
- Genentech executes another round of layoffs, with 3 VPs axed
- Humana to sell off minority stake in end-of-life care provider Gentiva
- Vitamin C May Be Key To A Healthier Brain As You Age
- New Vaccine Schedule Released By American College of Obstetricians & Gynecologists
- AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
- AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Novo reports data breach, tells clinical trial patients to 'remain vigilant'
- ‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff
- OIG: Frequent MA prior authorization denials for long-term care hospitals, inpatient rehab
- From Medicaid work requirement exemptions to AI safeguards in coverage: New AMA policies from annual meeting
- Joint initiative of 5 EU countries calls for 'unified approach' to pharma framework amid US drug pricing pressure
- J&J eyes rare disease expansion for blockbuster-to-be Imaavy with trial win
- Virtual care tech companies launch 'out-of-the-box' RPM tool for pharmacies
- Can Fasting Treat Gum Disease? Study Finds Reduced Inflammation
- Living With Cats Not Linked To Worse Asthma in Children
- Few Stroke, Brain Injury Survivors Get Top-Quality Hospital Rehab
- Popular Joint Pain Supplement, Glucosamine, Might Increase Alzheimer's Risk, Study Says
- Anguished Parents. Doctors In Tears. Utah's Long Measles Outbreak Takes A Toll.
- Madrigal takes giant inflatable liver on US tour in disease awareness push
- Listen to the Latest ‘KFF Health News Minute’
- Trump Bought Tobacco Stocks and Raked In Industry Donations as FDA Eased Standards
- Olixir NY teams with Crohn's & Colitis Foundation for ‘Spill Your Guts’ campaign
- Takeda’s TYK2 inhibitor beats Bristol Myers’ Sotyktu in phase 3 psoriasis showdown
- Hospital associations push CMS for higher 2027 pay bump, softer ramp-up for mandatory model
- AHIP 2026: Why Ascendiun CEO Paul Markovich is bullish on building out a digital health record for patients
- FDA’s Greenlight of Old Chemical Offers Chance To Restore Faith in Sunscreen
- Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows
- Weekly Rundown: Karias Health launches AI companion; Mount Sinai, Wisp partner to expand PrEP access in NY
- Sugary Beverages May Raise Your Risk of Liver Cancer
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Ardent Health's surprise CEO change reflected need for margin focus amid headwinds, CFO says
- FDA Approves First New Sunscreen Ingredient, Bemotrizinol, in Two Decades
- Trustees expect Medicare Trust Fund's reserves to run out in 2033
- Vega Health licenses AI models from Parkland Center for Clinical Innovation to predict patient risks
- Eli Lilly yells ‘action’ on authentic patient portrayals at Tribeca Festival
- Teen Recovering From Concussion? A 'Sweet Spot' For Screen Time Could Speed Up Their Recovery
- Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters
- AMA issues policy urging exemptions in upcoming Medicaid work requirements
- Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
- Teva to lay off 250 at API unit as search for new owner drags on: report
- Women Hit Harder By Sleep Apnea Than Men, Study Finds
- Retro Video Game Aids Stroke Recovery, Improves Arm Function
- Experimental, Once-Daily GLP-1 Pill, Elecoglipron, May Offer New Option for Weight Loss, Diabetes
- Anguished Parents. Doctors in Tears. Utah’s Long Measles Outbreak Takes a Toll.
- Looming Medicaid Cuts Supercharge California’s Latest Labor-Industry Fight
- Genentech and Novartis dish up food allergy microdrama series
- ‘I’m a lot more optimistic today’: Mike Doustdar tells Fierce about pivotal first year as Novo Nordisk CEO
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- How Much Alcohol Is Actually Safe? A New Study Challenges Old Advice
- AbbVie’s Skyrizi narrowly slides ahead of J&J’s Tremfya in May drug ad spending rankings
- Air Pollution Might Contribute To Clogged Arteries, Heart Disease Risk
- New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
- WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
- Merck, Gilead score in effort to develop the first weekly HIV pill
- Feeding Babies Eggs Sooner May Cut Allergy Risk, Study Suggests
- At A Tennessee Hospital, Nurse Stole Fentanyl And AI Missed It, State Records Say
- Infections A ‘Major Health Hazard’ For People With Diabetes, Large Study Warns
- MAHA's Treatments For Autism: Camel's Milk, Stem Cell Injections — And Spelling Therapy
- Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide
- Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide
- AI medical advice changes care decisions of most users: survey
- FDA Expands Sunscreen Options for the First Time in 20 Years
- Children's Well-Being Plummets Across 29 States, Report Finds
- Just 5 Minutes Of Prayer Helps Reduce Pain and Anxiety, Study Finds
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Irregular Sleep Risks Preschool Kids' Brain Power
- Why Alcohol Makes You Crave Salty Snacks — And How Protein-Rich Foods Can Help Prevent Weight Gain
- ADHD ‘Masking’ May Help People Blend In But Harms Mental Health
- Getting The RSV Shot, Abrysvo, While Pregnant Could Protect Your Baby After Birth
- Upcoming Billing Change Could Make Pregnancy Pricier
- Dengue Is No Longer Just A Travel Risk — What Google’s Mosquito Plan Could Mean For Your Summer
- Brain Surgery For Pituitary Tumor Helps Illinois Mom Have Second Baby
- Popular Blood Pressure Meds, Dihydropyridine Calcium-Channel Blockers, Linked To Kidney Damage Risk In Type 2 Diabetes
- Too Much Sitting In Pregnancy Doubles Risk Of Complications
- Spinal Cord Stimulation May Restore Arm Strength After Stroke
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
- Base Case: Remarks at the IC3 Blockchain Camp
- Commission Statement on the Passing of Former General Counsel David Becker
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
Michigan healthcare freedom community forum
Increasing penalties for fentanyl, and classifying them as Schedule I. That class is defined as drugs with no current medical use with high potential for abuse and/or addiction."The ultimate impact of this bill is taking fentanyl permanently away from pain and surgery patients.
What could possibly go wrong?
by Joyce Frieden, Washington Editor, MedPage Today May 26, 2023
The House passed a bill Thursday that proponents say is designed to reduce the number of people who become addicted to fentanyl, but opponents say it won't solve the problem and will just increase the number of people incarcerated for drug-related crimes.
The Halt All Lethal Trafficking of Fentanyl (HALT Fentanyl) Act passed by a vote of 289-133, with 215 Republicans and 74 Democrats voting in favor. The measure would:
- Permanently put fentanyl-related substances into Schedule I of the Controlled Substances Act. Currently, fentanyl is on Schedule I through Dec. 31, 2024, thanks to a temporary scheduling order issued by the Drug Enforcement Administration (DEA).
- Establish a new, alternative registration process for Schedule I research that is funded by HHS or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the FDA.
- Clarify that offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues. For example, offenses involving 100 g or more of a fentanyl-related substance will trigger a 10-year mandatory minimum prison term.
The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain situations, and waiving the requirement for a new inspection in some cases.
"With today's bipartisan vote in the House to advance the HALT Fentanyl Act, we are one step closer to curbing the devastating fentanyl poisoning crisis and saving American lives," Rep. Bob Latta (R-Ohio) said in a statement. "Illicit fentanyl is now the leading cause of death for people in the United States aged 18 to 49 ... This permanent labeling change is significant and needed because it will help get fentanyl-related substances off our streets and out of our communities. I now urge the Senate to take up this bill and send it to the president's desk to be signed into law."
House Speaker Kevin McCarthy (R-Calif.) applauded the bill's law enforcement provisions. "Due to the Biden administration's incompetence at the border, fentanyl has flowed into American communities and destroyed lives," he said in a statement. "The HALT Fentanyl Act is one needed tool to help stop the flow of fentanyl and provides law enforcement agencies the authority they need to help them adequately address this crime."
The Biden administration also praised the bill, specifically the permanent scheduling provision and a provision to make fentanyl research easier. "These two provisions are critical components of the Biden-Harris Administration's 2021 recommendations to Congress to combat the supply of illicit FRS [fentanyl-related substances] and save lives," the White House said in a statement. "The administration calls on Congress to pass all of these critical measures to improve public safety."
But others were not so happy. Despite multiple extensions of the Schedule I designation, "overdoses have not gone down, and we have unfortunately [not] made a dent in the incidence of opioid use disorders," Rep. Frank Pallone, Jr. (D-N.J.), ranking member of the House Energy & Commerce Committee, said on the House floor.
"Fentanyl and synthetic opioids continue to flood into the country. In testimony before our committee, the DEA administrator noted that DEA seized more than 50 million fake pills and 10,000 pounds of fentanyl in 2022 ... The HALT Fentanyl Act is a partisan distraction from the hard, bipartisan work that actually has to be done to address a long standing, intractable problem that faces our communities," he said.
"We simply cannot incarcerate our way out of a public health crisis," Pallone said. "The HALT Fentanyl Act does not provide any resources for research, prevention, treatment, recovery, or harm reduction. It also does not provide law enforcement or public health agencies with any additional resources to detect and intercept illicit drugs entering the country."
Several advocacy groups agreed. "Passage of the HALT Fentanyl Act and the draconian expansion of mandatory minimum sentencing for fentanyl-related substances contained in it would be a reckless repetition of the costly mistakes of the war on drugs that disproportionately impacts Black and Brown communities and creates the conditions for even more harmful illicit substances to enter the drug supply," Drew Gibson, director of advocacy for AIDS United, said in a statement.
"Any hope that we have of ending the overdose, HIV, and viral hepatitis epidemics in the United States lies in an embrace of evidence-based best practices and a rejection of the punitive and racially inequitable policies that have destroyed millions of lives over the last half-century," Gibson added.
"In passing the HALT Fentanyl Act, the House seems intent on doubling down on the same failed strategies that got us here to begin with," Maritza Perez Medina, director of the Office of Federal Affairs at the Drug Policy Alliance, said in a statement. "Increasing criminal penalties and expanding the use of mandatory minimums, as this bill does, has never reduced the supply or demand of illicit drugs. Instead, it only exacerbates racial disparities in the criminal legal system and creates the conditions for an even more unknown, and more potent, drug supply to flourish."
AIDS United, the Drug Policy Alliance, and other organizations are supporting the Support, Treatment, and Overdoses Prevention of Fentanyl Overdoses (STOP Fentanyl Overdoses) Act sponsored by Rep. Annie Kuster (D-N.H.). That bill would expand testing for fentanyl and related substances; increase information-sharing by public health departments and law enforcement in order to identify public health threats and prevent overdoses; and improve access to overdose reversal medications and substance use disorder treatment.
On the other side of the Capitol, the Senate version of the HALT Fentanyl Act was introduced by Sen. Bill Cassidy (R-La.) on March 30. It has been referred to the Senate Judiciary Committee but no other action has been taken on it.
https://www.medpagetoday.com/washington-watch/washington-watch/104730
And not a word about the border.
Joyce Frieden oversees MedPage Today’s Washington coverage, including stories about Congress, the White House, the Supreme Court, healthcare trade associations, and federal agencies. She has 35 years of experience covering health policy.
Michigan testimony on border concerns did contribute to this bill.
The Detroit News in February highlighted Rebecca Kiessling. New Detroit Congressman Shri Thanadar gets a line at the end.
'You're not protecting our children': Rochester Hills mom testifies about 2 sons' fentanyl deaths
Feb. 28, 2023Washington― A Michigan mother tearfully told House lawmakers the story Tuesday of her two sons' deaths from an accidental overdose of the opioid fentanyl, saying the government isn't doing enough to combat the opioid crisis and halt illegal drugs at the border.
"My children were taken away from me," saidRebecca Kiessling, a family law attorney and conservative activist from Rochester Hills.
"This should not be politicized. It's not about race. Fentanyl doesn't care about race. You talk about welcoming those crossing our border seeking protection? You're welcoming drug dealers across our border. You're giving them protection. You're not protecting our children."
Kiessling said her two sons, Caleb, 20, and Kyler, 18, died July 29, 2020, from fentanyl poisoning, along with 17-year-old Sophia Harris, when they took what they thought were Percocet pills that turned out to contain the drug fentanyl, a potent synthetic opioid drug that can be lethal in tiny amounts.
She said her sons' "dealer" was saved by a dose of the overdose-reversing spray Narcan and is serving prison time. Lorenzo Brabo was sentenced in 2021 to eight to 15 years in prison for providing the fentanyl that led to the three overdose deaths, according to reports.
"I don't use the term 'drug overdose' because this was not an overdose. This was murder," she said. "This is a war. Act like it. Do something."
Kiessling testified Tuesday morning before the Republican-led U.S. House Committee on Homeland Security, urging Congress and the White House to take the flow of illegal drugs over the Southern border more seriously. Prior to her sons' deaths, Kiessling said she didn't know what fentanyl was.
"I had heard of the opioid epidemic. I thought, you know, people are getting prescription drugs and getting addicted and then getting it on the streets, and that it affects their ability to work. I didn't know that people were dying," she said.
"I didn't know that my boys were taking anything that could kill them. They didn't think that they were either. They thought that they were safe with pills. ... But the government knew. The government's known for years and years."
Opioid overdose trends
Michigan experienced a 23% increase in opioid-related deaths from 1,768 in 2019 to 2,171 in 2020, when Kiessling's two sons died, according to state Department of Health and Human Services' statistics. The number rose to 2,539 deaths in 2021, a 17% jump. U.S. opioid-related deaths rose from 68,630 in 2020 to 80,411 in 2021, according to theNational Institute on Drug Abuse.
Kiessling highlighted the tally of drug-related deaths the year that Caleb was born — 20,000 in 2000 — and the surge of 100,000 like deaths in 2020.
"If we had Chinese troops lining up along our Southern border with weapons aimed at our people, with weapons of mass destruction aimed at our cities, you damn well know you would do something about it," she said.
"We have a weather balloon from China going across the country. Nobody died, and everybody's freaking out about it. But 100,000 die every year, and nothing's being done. Not enough is being done."
Kiessling started crying as she read from a paper written by Kyler weeks before his death, advising to "stay away from drugs and alcohol."
"It's not worth it," he wrote.
Kyler, who had graduated from high school the day before his death, also wrote in a list that he wanted to start working more to stay focused, have a better relationship with his parents, to report to all drug tests and "find another method to cope that works for me," according to his mother.
Caleb, Kiessling said, had started speaking in schools to encourage kids not to try drugs. He wrote a testimony to share with them, saying that he'd "dabbled" in drugs but had stayed away from crack and heroine because he'd grown up "watching my birth mother ruin her life and watch all her friends pass away from heroin overdoses."
Kiessling said later in the hearing that the boys' birth mother died six months after they did.
Lawmakers respond
Committee Chairman Mark Green, R-Tennessee, blamed the Biden administration for border policies that he said have contributed to the "surge" in migrants at the border, "and the drug cartels have taken advantage of the situation."
Kiessling's sons died in 2020, when Donald Trump was president and was trying to extend a wall across the Southern border.
The Biden administration has touted itsoverdose epidemic strategy, which has included spending $1.5 billion on grants for aid to treatment programs and law enforcement. The U.S. Department of the Treasury is using sanctions to target the global fentanyl supply chain, especially in Mexico, administration officials have said.
The Biden administration in February also proposed a rule that migrants seeking to enter the United States will be assumed inadmissible if they "circumvent available, established pathways to lawful migration," including entering the country between ports of entry or arriving at a port of entry without a scheduled appointment.The proposal also rejects those who fail to seek protection in countries through which they pass while heading to the United States.
Green asked Kiessling how her community has been affected by the opioid crisis. She replied that some parents and siblings whom she knows from support groups had committed suicide.
"It's devastating families," she said. "It's been very difficult for my (three) daughters. One daughter, she went off to Michigan State and came home after a semester. It was just too painful."
One of Kyler's friends approached her at a restaurant last summer and said he'd stopped doing any kind of drugs in response to his death, Kiessling said.
"He said, 'I want you to know that your son's death started a movement in our hometown, so that when people show up with pills, they're ostracized, and they're condemned,' he said," Kiessling recounted. "But, you know, for how long? How many of the kids in the high schools now know about my son's deaths?"
Rep. Marjorie Taylor Greene, R-Georgia, also lamented the surge in fentanyl deaths, saying it's become a top cause of death for Americans ages 18 to 45 years old.
"This is unforgivable," said Greene, thanking Kiessling for sharing her story and saying her sons' deaths "should never have happened."
Kiessling responded in part by criticizing witness testimony from the Cato Institute's David Bier, who suggested that policymakers should focus on demand and not supply to reduce drug deaths.
"What I'm hearing him saying is, 'They asked for it.' Seriously, are you kidding me?" Kiessling said. "We need to protect our children. They didn't ask for that. This wasn't demand that they wanted the fentanyl. They thought they were getting Percocet, OK?"
Rep. Donald Payne Jr., D-New Jersey, said most illegal drugs are smuggled through ports of entry into the United States "unfortunately" by U.S. citizens, and usually hidden in vehicles, cargo, or on a person in the hopes "it won't be detected."
Payne suggested lawmakers should focus on what policy changes can be made to allow personnel at ports of entry to focus on the interdiction of drugs.
It was the first full committee hearing for freshman Rep. Shri Thanedar, D-Detroit, a former businessman and Indian immigrant who spoke of the importance of the Northern border.
"Unfortunately, a shortage of pathways for immigration has made our borders very difficult to manage. CBP has had to rely on temporary duty assignments to surge employees where they are most needed, which has often pulled resources away from the northern border," Thanedar said. "As an immigrant myself, I'm a proud example of how immigrants contribute to American society."
Melissa Nann Burke covers Washington for The Detroit News, including Michigan's congressional delegation, the White House and U.S. Supreme Court.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















